192 related articles for article (PubMed ID: 23807455)
1. Angiotensin II type 2 receptor (AT2R) is associated with increased tolerance of the hyperthyroid heart to ischemia-reperfusion.
Tavares FM; da Silva IB; Gomes DA; Barreto-Chaves ML
Cardiovasc Drugs Ther; 2013 Oct; 27(5):393-402. PubMed ID: 23807455
[TBL] [Abstract][Full Text] [Related]
2. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning.
Pantos C; Paizis I; Mourouzis I; Moraitis P; Tzeis S; Karamanoli E; Mourouzis C; Karageorgiou H; Cokkinos DV
Horm Metab Res; 2005 Aug; 37(8):500-4. PubMed ID: 16138263
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.
da Silva IB; Gomes DA; Alenina N; Bader M; Dos Santos RA; Barreto-Chaves MLM
Heart Vessels; 2018 Jun; 33(6):671-681. PubMed ID: 29218410
[TBL] [Abstract][Full Text] [Related]
4. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Pflugers Arch; 2007 Apr; 454(1):75-81. PubMed ID: 17206447
[TBL] [Abstract][Full Text] [Related]
6. Increased AT(2)R protein expression but not increased apoptosis during cardioprotection induced by AT(1)R blockade.
Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
Can J Cardiol; 2002 Oct; 18(10):1107-16. PubMed ID: 12420045
[TBL] [Abstract][Full Text] [Related]
7. Increased AT2R protein expression but not increased apoptosis during cardioprotection induced by AT1R blockade.
Moudgil R; Musat-Marcu S; Xu Y; Kumar D; Jugdutt BI
Can J Cardiol; 2002 Aug; 18(8):873-83. PubMed ID: 12215750
[TBL] [Abstract][Full Text] [Related]
8. Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury. Relation to cardiac renin-angiotensin system.
Zhang Y; Xu S
Chin Med J (Engl); 1995 Jan; 108(1):28-32. PubMed ID: 7712835
[TBL] [Abstract][Full Text] [Related]
9. Protection of the myocardium against ischemia/reperfusion injury by angiotensin-(1-9) through an AT
Mendoza-Torres E; Riquelme JA; Vielma A; Sagredo AR; Gabrielli L; Bravo-Sagua R; Jalil JE; Rothermel BA; Sanchez G; Ocaranza MP; Lavandero S
Pharmacol Res; 2018 Sep; 135():112-121. PubMed ID: 30048754
[TBL] [Abstract][Full Text] [Related]
10. Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia-reperfusion model.
Halapas A; Lembessis P; Mourouzis I; Pantos C; Cokkinos DV; Sourla A; Koutsilieris M
Exp Physiol; 2008 Feb; 93(2):237-46. PubMed ID: 17911357
[TBL] [Abstract][Full Text] [Related]
11. The role of NO in ischemia/reperfusion injury in isolated rat heart.
Andelová E; Barteková M; Pancza D; Styk J; Ravingerová T
Gen Physiol Biophys; 2005 Dec; 24(4):411-26. PubMed ID: 16474186
[TBL] [Abstract][Full Text] [Related]
12. Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats.
Penna C; Tullio F; Perrelli MG; Moro F; Abbadessa G; Piccione F; Carriero V; Racca S; Pagliaro P
Basic Res Cardiol; 2011 May; 106(3):409-20. PubMed ID: 21174210
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin E on the response to ischemia-reperfusion of Langendorff heart preparations from hyperthyroid rats.
Venditti P; Masullo P; Agnisola C; Di Meo S
Life Sci; 2000 Jan; 66(8):697-708. PubMed ID: 10680578
[TBL] [Abstract][Full Text] [Related]
14. Maternal hyperthyroidism increases the susceptibility of rat adult offspring to cardiovascular disorders.
Lino CA; da Silva IB; Shibata CE; Monteiro Pde S; Barreto-Chaves ML
Mol Cell Endocrinol; 2015 Nov; 416():1-8. PubMed ID: 26277399
[TBL] [Abstract][Full Text] [Related]
15. Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70.
Pantos C; Malliopoulou V; Mourouzis I; Thempeyioti A; Paizis I; Dimopoulos A; Saranteas T; Xinaris C; Cokkinos DV
Horm Metab Res; 2006 May; 38(5):308-13. PubMed ID: 16718626
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy in the post-ischemic metabolic and functional recovery profiles of isolated blood-versus buffer-perfused heart.
Galiñanes M; Bernocchi P; Argano V; Cargnoni A; Ferrari R; Hearse DJ
J Mol Cell Cardiol; 1996 Mar; 28(3):531-9. PubMed ID: 9011636
[TBL] [Abstract][Full Text] [Related]
17. Blockage of angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation.
Carneiro-Ramos MS; Diniz GP; Nadu AP; Almeida J; Vieira RL; Santos RA; Barreto-Chaves ML
Basic Res Cardiol; 2010 May; 105(3):325-35. PubMed ID: 20155476
[TBL] [Abstract][Full Text] [Related]
18. Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
Taniguchi Y; Takahashi N; Fukui A; Nagano-Torigoe Y; Thuc LC; Teshima Y; Shinohara T; Wakisaka O; Ooie T; Murozono Y; Yufu K; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
Cardiovasc Res; 2011 Dec; 92(3):439-48. PubMed ID: 21952935
[TBL] [Abstract][Full Text] [Related]
19. Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts.
Nuñez RE; Javadov S; Escobales N
Pflugers Arch; 2018 Sep; 470(9):1391-1403. PubMed ID: 29748710
[TBL] [Abstract][Full Text] [Related]
20. Role of Mas receptor antagonist (A779) on pressure diuresis and natriuresis and renal blood flow in the absence of angiotensin II receptors type 1 and 2 in female and male rats.
Mansoori A; Oryan S; Nematbakhsh M
J Physiol Pharmacol; 2014 Oct; 65(5):633-9. PubMed ID: 25371522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
